Altimmune, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ALT on Nasdaq
Industry
Pharmaceutical Preparations
Location
910 Clopper Road, Suite 201 S, Gaithersburg, MD

Insiders trading volume in the past year

Altimmune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vipin K. Garg President and CEO, Director $2.36M Jan 30, 2025
Matthew Scott Harris Chief Medical Officer $458K Jul 31, 2025
Richard I. Eisenstadt Chief Financial Officer $441K Jan 30, 2024
David Drutz Director $382K Aug 19, 2024
M. Scot Roberts Chief Scientific Officer $233K Jul 31, 2025
William Michael Brown Chief Financial Officer $199K Jul 31, 2021
Raymond M. Jordt Chief Business Officer $114K Jul 31, 2025
Andrew Shutterly Acting Chief Financial Officer $61.5K Jul 31, 2024
Gregory Weaver Chief Financial Officer $52K +$52K Oct 1, 2025
Catherine A. Sohn Director $5.79K +$5.79K Sep 25, 2025
John Gill Director $0 Sep 25, 2025
Philip Hodges Director Sep 25, 2025
Christophe Arbet-Engels Chief Medical Officer Oct 1, 2025
Mitchel Sayare Director Sep 25, 2025
Linda M. Richardson Chief Commercial Officer Sep 16, 2025
Teri L. Lawver Director Sep 25, 2025
Jerome Benedict Durso Director Sep 25, 2025
Wayne Pisano Director Sep 25, 2025
Diane Jorkasky Director Sep 25, 2025
Klaus Schafer Director Sep 25, 2025

Recent Insider Transactions by Companies or Individuals for Altimmune, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.